Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Seiko Ohta"'
Autor:
Naoki Nakaya, Miyuki Maruyama, Seiko Ohta, Aya Tsuchiya, Mami Muramatsu, Kenji Omura, Soichiro Ueno, Megumi Hagihara, Yoshiko Onodera, Hideo Nakajima, Itaru Sato, Yukie Iijima
Publikováno v:
Oncology letters. 10(6)
In order to examine the effect on body composition of anticancer drug treatments, the body composition rate in patients being treated with gemcitabine (GEM)-based chemotherapy was measured over time on an outpatient basis with a simple body compositi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::283ca97948c058786935b715f203b875
https://pubmed.ncbi.nlm.nih.gov/26788165
https://pubmed.ncbi.nlm.nih.gov/26788165
Autor:
Mitsunori Sawada, Seiko Ohta, Fujio Numano, Shinya Sakita, Takashi Ashikaga, Masahiro Tatsumi, Yukio Kishi, Natsuko Kasuya
Publikováno v:
Journal of Cardiovascular Pharmacology. 36:65-70
3-Isobutyryl-2-isopropylpyrazolo[1,5-a]pyridine (ibudilast) has been widely used in Japanese clinics for its antiasthmatic and antithrombotic effects. We investigated the mechanisms involved in the antiplatelet effects of the agent, specifically focu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2adbc5685e4910dab8c4594755f3896
https://doi.org/10.1097/00005344-200007000-00009
https://doi.org/10.1097/00005344-200007000-00009
Autor:
Ryoji Watanabe, Fujio Numano, Yukio Kishi, Yoshiaki Maruyama, Yasushi Kobayashi, Takashi Ashikaga, Seiko Ohta, Shinya Sakita, Tomoyuki Watanabe
Publikováno v:
Journal of Atherosclerosis and Thrombosis. 4:144-148
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::274fc2b02b11fba4ba1b3cb5b77a0590
https://doi.org/10.5551/jat1994.4.144
https://doi.org/10.5551/jat1994.4.144
Publikováno v:
Journal of hypertension. 21(7)
OBJECTIVES Recent clinical trials have demonstrated that angiotensin-converting enzyme inhibitors (ACEIs) reduce thrombotic events by unknown mechanisms in patients with atherosclerotic cardiovascular diseases. DESIGN We studied the in-vitro effects
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02773959f43b67ec73727bc1a9e7827e
https://pubmed.ncbi.nlm.nih.gov/12817169
https://pubmed.ncbi.nlm.nih.gov/12817169
Publikováno v:
Cardiovascular drug reviews. 19(3)
Ibudilast (3-isobutyryl-2-isopropylpyrazolo[1,5-a]pyridine) is a nonselective inhibitor of cyclic nucleotide phosphodiesterase (PDE). It is widely used in Japan for improving prognosis and relieving symptoms in patients suffering from ischemic stroke
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60178cb2fde99c045afc13c14520981c
https://pubmed.ncbi.nlm.nih.gov/11607039
https://pubmed.ncbi.nlm.nih.gov/11607039
Autor:
Yukio Kishi, Takashi Ashikaga, Fujio Numano, Ryoji Watanabe, Tomoyuki Watanabe, Seiko Ohta, Shinya Sakita
Publikováno v:
Annals of the New York Academy of Sciences. 811
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57a984631d894bc87f17353876b02172
https://pubmed.ncbi.nlm.nih.gov/9186632
https://pubmed.ncbi.nlm.nih.gov/9186632
Autor:
MAMI MURAMATSU, AYA TSUCHIYA, SEIKO OHTA, YUKIE IIJIMA, MIYUKI MARUYAMA, YOSHIKO ONODERA, MEGUMI HAGIHARA, NAOKI NAKAYA, ITARU SATO, KENJI OMURA, SOICHIRO UENO, HIDEO NAKAJIMA
Publikováno v:
Oncology Letters; Dec2015, Vol. 10 Issue 6, p3535-3541, 7p